We are only able to display limited information for this firm. We display more complete information for all of the following firms:
O'Melveny is well known for bringing Chinese life sciences and biotech companies to the public markets in Hong Kong and the US. The China life sciences and healthcare practice also covers IP and licensing matters, along with M&A, private equity, and venture capital transactions. The lead partner for the China capital markets team, Ke Geng in Beijing advises on pharmaceutical, biotech and life sciences-related IPOs and equity financings in China. Ke Zhu is a capital markets specialist in Hong Kong.
Legal 500 Editorial commentary
Key clients
- Acotec Scientific
- Adlai Nortye
Abbreviated data is displayed for this firm.
Work highlights
- Advised Acotec Scientific on a voluntary partial offer by Boston Scientific Group.
- Advised Adlai Nortye on its Nasdaq IPO.
Abbreviated data is displayed for this firm.